Jasper Hellweg
Stock Analyst at Argus Research
(2.12)
# 2,873
Out of 5,173 analysts
92
Total ratings
47.22%
Success rate
3.44%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Buy | $360 → $400 | $349.77 | +14.36% | 1 | Feb 6, 2026 | |
| BAX Baxter International | Downgrades: Hold | n/a | $16.61 | - | 3 | Oct 31, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $190 | $115.23 | +64.89% | 7 | Sep 9, 2025 | |
| BIIB Biogen | Downgrades: Hold | n/a | $183.64 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $521.22 | -23.26% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $123.79 | +21.17% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $44.77 | +34.02% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $736.53 | +58.85% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $451.24 | +21.89% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $184.07 | -53.82% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $36.82 | +239.49% | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $140 | $51.28 | +173.01% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $204.93 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $28.77 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $166.96 | +73.69% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $85.33 | +17.19% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $264.42 | +11.56% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.05 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $195.60 | -30.98% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.57 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $179.65 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $200.36 | - | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $27.85 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $494.58 | -68.66% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $57.71 | +55.95% | 1 | Sep 19, 2018 |
Amgen
Feb 6, 2026
Maintains: Buy
Price Target: $360 → $400
Current: $349.77
Upside: +14.36%
Baxter International
Oct 31, 2025
Downgrades: Hold
Price Target: n/a
Current: $16.61
Upside: -
Zoetis
Sep 9, 2025
Reiterates: Buy
Price Target: $190
Current: $115.23
Upside: +64.89%
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $183.64
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $521.22
Upside: -23.26%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $123.79
Upside: +21.17%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $44.77
Upside: +34.02%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $736.53
Upside: +58.85%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $451.24
Upside: +21.89%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $184.07
Upside: -53.82%
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $36.82
Upside: +239.49%
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $51.28
Upside: +173.01%
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $204.93
Upside: -
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $28.77
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $166.96
Upside: +73.69%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $85.33
Upside: +17.19%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $264.42
Upside: +11.56%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.05
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $195.60
Upside: -30.98%
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $9.57
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $179.65
Upside: -
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $200.36
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $27.85
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $494.58
Upside: -68.66%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $57.71
Upside: +55.95%